Lymphoma and the Collision Repair Industry
Many people, both in the medical professions and ordinary folks wonder what causes lymphoma. As lymphoma is actually over thirty different types of cancer, there are likely multiple answers.
Todays inquiry comes from an article on Steve Carey, who was diagnosed with lymphoma 3 years ago. When asking around, he found that other people in his industry, collision repair, noticed an increased incidence of lymphoma. Several reputable groups like the Leukemia & Lymphoma Society report a possible link. There are also many "lawyer" sites on the Net - supposed information sites set up by law firms to get innocent cancer patients to file claims.
If you are interested in the subject, there is an extensive article entitled Non-Hodgkin lymphoma and benzene exposure: A systematic literature review in Chemico-Biological Interactions Volumes 153-154 , 30 May 2005, Pages 231-237
If you are in the collision repair industry, Carey is asking people to contact him at [email protected]
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
